Skip to main content
. Author manuscript; available in PMC: 2017 Dec 19.
Published in final edited form as: Microb Drug Resist. 2014 Aug 12;21(2):121–129. doi: 10.1089/mdr.2014.0086

Table 4.

Summary of Alterations Found in L4, L22, and 23s rRNA, Among ERY-Resistant (erm - /mef -, n = 37) and Q/D Nonsusceptible Isolates (n = 18)

Gene Mutationa Observed phenotypeb Reported phenotypeb Reference
rplD/L4 E13Q, E30Q, V88I, G98A, A128S, S130E See notes c and d No resistance 56
E30K Q-D M 54
S112L See note d This study
Q67R + R72G Q-D LZD LZD 14
69GTG71 to TPS MSB ML, M, MSB 17, 50, 56
63KPWRQKTGTGRAR74 M This study
63KPWRQKGKGTGRAR74 Q-D ERY-I AZI-R 37 e
63KPWRQKGSQKGTGRAR74 M Q-D This study
63KPWRPWRQKGTGRAR74 Q-D This study
rplV/L22 R103C M Q-D This study
102KRTAHITRTAHIVA110 M Q-D M Q-D 29
102KRTAHITRTAHITVA110 M Q-D ML, M, M Q-D 17, 40
102KRTAHITKRTAHIVA110 M Q-D M Q-D 6
102KRTAHITKRTAHITVA110 M Q-D This study
102KRTAHITVRTAHITVA110 M Q-D This study
T85P See note 4 This study
85PMKRFRPPMKRFRPRAK94 M Q-D This study
85TMKRFRPRASFRPRAK94 M Q-D This study
76SEAFANEGPTIAFANEGPTM86 M Q-D This study
23s d. V A2061G (2059 in Escherichia coli) M, MLSB ML, MLSB, MSB 16, 49, 50, 54
C2613G (2611 in E. coli) M Q-D M, M Q-D 16, 49, 52
A2060C (2058 in E. coli) MLSB ML, M 33, 42, 52e
a

Insertions are underlined.

b

“Observed phenotype” refers to this study, while “Reported phenotype” refers to phenotypes observed in previous reports.

c

These changes were found in combination with the 69GTG71 to TPS substitution.

d

Only found in combination with other changes, its role in resistance is unclear.

e

These reports pertain to other bacterial species. Our study is the first to report these changes in Streptococcus pneumoniae.

AZI, azithromycin; ERY, erythromycin; LZD, linezolid; L, lincosamides; M, macrolides; SB, streptogramin B; Q-D, quinupristin–dalfopristin (Synercid).